EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Klinische Studie (Phase II)Open Access · CC BY 4.0

Efficacy and safety of entrectinib in children with extracranial solid or central nervous system (CNS) tumours harbouring NTRK or ROS1 fusions

Ami V Desai, Aditi Bagchi, Amy E Armstrong, Cornelis M van Tilburg, Ellen M Basu, Giles W Robinson, Huanmin Wang, Michela Casanova, Nicolas André, Quentin Campbell-Hewson, Yeming Wu, Alison Cardenas und 8 weitere

European Journal of Cancer · 2025

DOI: 10.1016/j.ejca.2025.115308 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Ami V Desai und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Section of Hematology/Oncology/Stem Cell Transplantation, University of Chicago Medical Center, 5721 S. Maryland Ave., Chic…. Hauptthemen laut MEDLINE: Central Nervous System Neoplasms, Oncogene Proteins, Fusion, Protein Kinase Inhibitors, Protein-Tyrosine Kinases. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, F. Hoffmann-La Roche Ltd, F. Hoffmann-La Roche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Nervous System NeoplasmsOncogene Proteins, FusionProtein Kinase InhibitorsProtein-Tyrosine KinasesProto-Oncogene ProteinsReceptor, trkAReceptor, trkCAdolescentChildChild, PreschoolFemaleHumansInfantMaleBenzamidesIndazolesReceptor, trkBTreatment OutcomeMembrane Glycoproteins

Stichwörter der Autor:innen

CNS tumoursEntrectinibNTRK fusionsPaediatric tumoursROS1 fusionsROS1 inhibitorSTARTRK-2STARTRK-NGTAPISTRYTRK inhibitor

Substanzen

BenzamidesentrectinibIndazolesNTRK1 protein, humanNTRK3 protein, humanOncogene Proteins, FusionProtein Kinase InhibitorsProtein-Tyrosine KinasesProto-Oncogene ProteinsReceptor, trkA

Autor:innen und Institutionen

  • Department of Pediatrics, Section of Hematology/Oncology/Stem Cell Transplantation, University of Chicago Medical Center, 5721 S. Maryland Ave., Chicago, IL 60637, USA. Electronic address: adesai12@bsd.uchicago.edu.
  • Division of Neuro-Oncology, Department of Oncology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, MS 260, Memphis, TN 38105, USA. Electronic address: aditi.bagchi@stjude.org.
  • Division of Pediatric Hematology/Oncology, Washington University School of Medicine in St. Louis, 660 S. Euclid Ave., St. Louis, MO 63110-1010, USA. Electronic address: armstrongae@wustl.edu.
  • Hopp Children's Cancer Center Heidelberg, Im Neuenheimer Feld 430, Heidelberg 69120, Germany; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center, Im Neuenheimer Feld 280, Heidelberg 69120, Germa…
  • Department of Pediatrics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA. Electronic address: basue@mskcc.org.
  • Division of Neuro-Oncology, Department of Oncology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, MS 260, Memphis, TN 38105, USA. Electronic address: giles.robinson@stjude.org.

Förderung

  • NCI NIH HHS
  • F. Hoffmann-La Roche Ltd
  • F. Hoffmann-La Roche
  • St. Jude Children's Research Hospital
  • Children’s Oncology Group

Zitieren

APA

Desai, A. V., Bagchi, A., Armstrong, A. E., van Tilburg, C. M., Basu, E. M., Robinson, G. W., Wang, H., Casanova, M., André, N., Campbell-Hewson, Q., Wu, Y., Cardenas, A., Ci, B., Ryklansky, C., Devlin, C. E., Meneses-Lorente, G., Wulff, J., Hutchinson, K. E., Gajjar, A., & Fox, E. (2025). Efficacy and safety of entrectinib in children with extracranial solid or central nervous system (CNS) tumours harbouring NTRK or ROS1 fusions. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.115308

Vancouver

Desai AV, Bagchi A, Armstrong AE, van Tilburg CM, Basu EM, Robinson GW, et al. Efficacy and safety of entrectinib in children with extracranial solid or central nervous system (CNS) tumours harbouring NTRK or ROS1 fusions. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.115308

BibTeX
@article{Desai2025,
  author = {Desai, Ami V and Bagchi, Aditi and Armstrong, Amy E and van Tilburg, Cornelis M and Basu, Ellen M and Robinson, Giles W and Wang, Huanmin and Casanova, Michela and André, Nicolas and Campbell-Hewson, Quentin and Wu, Yeming and Cardenas, Alison and Ci, Bo and Ryklansky, Carolina and Devlin, Clare E and Meneses-Lorente, Georgina and Wulff, Jade and Hutchinson, Katherine E and Gajjar, Amar and Fox, Elizabeth},
  title = {Efficacy and safety of entrectinib in children with extracranial solid or central nervous system (CNS) tumours harbouring NTRK or ROS1 fusions},
  journal = {European Journal of Cancer},
  year = {2025},
  doi = {10.1016/j.ejca.2025.115308}
}
Kostenlos starten →